Neuromodulation Devices
•26 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (26)
| Company | Market Cap | Price |
|---|---|---|
|
BSX
Boston Scientific Corporation
Neuromodulation devices including Intracept intraosseous nerve ablation system.
|
$149.01B |
$100.73
+0.16%
|
|
SYK
Stryker Corporation
OptaBlate BVN system is a neuromodulation/pain-management device.
|
$136.19B |
$355.94
-3.53%
|
|
MDT
Medtronic plc
Neuromodulation Devices cover the spine and brain stimulation technologies (e.g., Inceptiv, Percept) highlighted in the pipeline.
|
$116.21B |
$90.71
-0.29%
|
|
GMED
Globus Medical, Inc.
Neuromodulation devices via Nevro spinal cord stimulation platform and expansion.
|
$8.18B |
$60.35
-0.61%
|
|
LIVN
LivaNova PLC
Directly manufactures/distributes Neuromodulation Devices, including VNS Therapy and proximal hypoglossal nerve stimulation systems.
|
$2.87B |
$52.65
-0.27%
|
|
ATEC
Alphatec Holdings, Inc.
SafeOp neural monitoring systems used during spine surgery.
|
$2.81B |
$18.98
+16.26%
|
|
ITGR
Integer Holdings Corporation
Neuromodulation devices are a high-growth served market for Integer and align with its product portfolio.
|
$2.26B |
$64.53
+1.91%
|
|
INSP
Inspire Medical Systems, Inc.
Inspire V is a neuromodulation device designed to treat obstructive sleep apnea, representing Inspire's core product category.
|
$2.13B |
$72.03
-1.42%
|
|
PCRX
Pacira BioSciences, Inc.
IOvera's mechanism relates to neuromodulation/nerve-targeted therapy, aligning with Neuromodulation Devices.
|
$989.99M |
$21.42
+0.71%
|
|
BVS
Bioventus Inc.
Peripheral Nerve Stimulation products (TalisMann, StimTrial) are neuromodulation devices.
|
$538.05M |
$6.55
-3.25%
|
|
AVNS
Avanos Medical, Inc.
The RFA portfolio (ESENTEC, TRIDENT, COOLIEF) places Avanos in the neuromodulation devices category.
|
$513.77M |
$11.09
-0.45%
|
|
NPCE
NeuroPace, Inc.
Core product Neuromodulation device (RNS System) delivering brain-responsive, on-demand therapy for drug-resistant epilepsy.
|
$326.02M |
$9.92
+0.61%
|
|
BWAY
BrainsWay Ltd.
Core product: BrainsWay's Deep TMS neuromodulation devices.
|
$280.07M |
$16.85
-0.82%
|
|
CVRX
CVRx, Inc.
CVRx's Barostim is a neuromodulation device (implantable) that modulates the autonomic nervous system via baroreflex activation for heart failure.
|
$265.68M |
$10.18
-4.32%
|
|
NYXH
Nyxoah S.A.
Genio is a neuromodulation implant system (implantable medical device) for obstructive sleep apnea.
|
$178.48M |
$5.07
+0.80%
|
|
STIM
Neuronetics, Inc.
NeuroStar Advanced Therapy System is a non-invasive neuromodulation device; the direct product of the company.
|
$174.42M |
$2.64
-2.22%
|
|
OBIO
Orchestra BioMed Holdings, Inc.
AVIM therapy uses neuromodulation to affect autonomic nervous system responses, fitting Neuromodulation Devices.
|
$149.42M |
$3.89
-2.99%
|
|
VANI
Vivani Medical, Inc.
Vivani's Neurostimulation division (Cortigent) assets exist and are being spun off, representing Neuromodulation Devices.
|
$95.38M |
$1.63
-3.55%
|
|
NMTC
NeuroOne Medical Technologies Corporation
Core product category: neuromodulation devices used to treat epilepsy and pain via brain stimulation and ablation.
|
$39.46M |
$0.79
-0.87%
|
|
ECOR
electroCore, Inc.
Directly markets and sells neuromodulation medical devices (gammaCore, Quell, Truvaga, Sparrow Ascent, TAC-STIM).
|
$37.40M |
$5.02
+2.87%
|
|
ZYXI
Zynex, Inc.
NexWave and TensWave are neuromodulation/electrotherapy devices, placing the company in the neuromodulation devices category.
|
$34.77M |
$1.16
-7.20%
|
|
NXL
Nexalin Technology, Inc.
Core product is non-invasive neuromodulation devices for brain stimulation (Gen-2 SYNC, Gen-3 HALO).
|
$25.77M |
$1.53
|
|
NRXS
NeurAxis, Inc.
Core product line: Neuromodulation devices (IB-Stim PENFS).
|
$19.63M |
$2.72
-2.51%
|
|
COCH
Envoy Medical, Inc.
Cochlear implants operate by neuromodulating auditory pathways, classifying them as neuromodulation devices.
|
$17.17M |
$0.80
+6.84%
|
|
AMIX
Autonomix Medical, Inc. Common Stock
Core platform is a catheter-based Neuromodulation Device designed to sense and ablate peripheral nerves.
|
$2.86M |
$1.02
-0.97%
|
|
HSDT
Solana Company
PoNS is a non-invasive neuromodulation device produced by the company for gait and balance rehabilitation.
|
$62732 |
$5.99
+0.17%
|
Loading company comparison...
Loading industry trends...
Loading research report...
